T1	Participants 403 743	thirty-seven adult patients were exposed for eight hours in an environmental exposure chamber (EEC) to birch pollen at an average concentration of 3500 ± 500 grains/m(3) , then randomized to four maintenance dose groups of rBet v 1-FV and one placebo group: 20 μg (n = 7), 80 μg (n = 8), 160 μg (n = 7), 320 μg (n = 8), and placebo (n = 7).
T2	Participants 950 1008	Thirty-six patients were evaluable for efficacy assessment
T3	Participants 744 832	Patients were treated for 10 weeks with weekly injections and then re-exposed in the EEC
